Role of maintenance therapy after autologous stem cell transplant for multiple myeloma: lessons for cancer therapy.
作者信息
Kyle Robert A
机构信息
Division of Hematology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA.
出版信息
Mayo Clin Proc. 2011 May;86(5):419-20. doi: 10.4065/mcp.2011.0171.
Abstract
摘要
相似文献
1
Role of maintenance therapy after autologous stem cell transplant for multiple myeloma: lessons for cancer therapy.自体干细胞移植后维持治疗在多发性骨髓瘤中的作用：癌症治疗的经验教训。
Mayo Clin Proc. 2011 May;86(5):419-20. doi: 10.4065/mcp.2011.0171.
2
Maintenance treatment in multiple myeloma.多发性骨髓瘤的维持治疗
Ann Oncol. 2008 Jun;19 Suppl 4:iv54-5. doi: 10.1093/annonc/mdn197.
3
Maintenance therapy for multiple myeloma.多发性骨髓瘤的维持治疗
Hematol Oncol Clin North Am. 2014 Oct;28(5):839-59. doi: 10.1016/j.hoc.2014.06.006. Epub 2014 Jul 22.
4
Canadian cost analysis comparing maintenance therapy with bortezomib versus lenalidomide for patients with multiple myeloma post autologous stem cell transplant.加拿大针对自体干细胞移植后的多发性骨髓瘤患者，比较硼替佐米与来那度胺维持治疗的成本分析。
J Popul Ther Clin Pharmacol. 2016;23(1):e103-13. Epub 2016 Jun 7.
5
Autologous transplantation and maintenance therapy in multiple myeloma.自体移植和多发性骨髓瘤的维持治疗。
N Engl J Med. 2014 Sep 4;371(10):895-905. doi: 10.1056/NEJMoa1402888.
6
New treatments in multiple myeloma: beyond optimal treatment.多发性骨髓瘤的新疗法：超越最佳治疗
Ann Oncol. 2008 Jul;19 Suppl 5:v68-70. doi: 10.1093/annonc/mdn314.
7
Evolving role of stem cell transplantation in multiple myeloma.干细胞移植在多发性骨髓瘤中不断演变的作用。
Clin Lymphoma Myeloma. 2005 Sep;6(2):89-95. doi: 10.3816/CLM.2005.n.034.
8
Risk adapted post-transplant maintenance in multiple myeloma.多发性骨髓瘤的风险适应性移植后维持治疗。
Expert Rev Hematol. 2019 Feb;12(2):107-118. doi: 10.1080/17474086.2019.1576521.
9
Treatment trade-offs in myeloma: A survey of consecutive patients about contemporary maintenance strategies.多发性骨髓瘤的治疗权衡：对连续患者进行当代维持治疗策略的调查。
Cancer. 2013 Dec 15;119(24):4308-15. doi: 10.1002/cncr.28340. Epub 2013 Sep 19.
10
Advances in maintenance strategy in newly diagnosed multiple myeloma patients eligible for autologous transplantation.适合自体移植的初诊多发性骨髓瘤患者维持治疗策略的进展。
Expert Rev Hematol. 2020 Dec;13(12):1333-1347. doi: 10.1080/17474086.2020.1839886. Epub 2020 Oct 26.
引用本文的文献
1
Smoldering multiple myeloma requiring treatment: time for a new definition?冒烟型多发性骨髓瘤需要治疗：是否需要新的定义？
Blood. 2013 Dec 19;122(26):4172-81. doi: 10.1182/blood-2013-08-520890. Epub 2013 Oct 21.
2
Treatment trade-offs in myeloma: A survey of consecutive patients about contemporary maintenance strategies.多发性骨髓瘤的治疗权衡：对连续患者进行当代维持治疗策略的调查。
Cancer. 2013 Dec 15;119(24):4308-15. doi: 10.1002/cncr.28340. Epub 2013 Sep 19.
3
Efficacy of bortezomib as first-line treatment for patients with multiple myeloma.硼替佐米作为一线治疗多发性骨髓瘤患者的疗效。
Clin Med Insights Oncol. 2013;7:53-73. doi: 10.4137/CMO.S7764. Epub 2013 Feb 28.
本文引用的文献
1
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study.硼替佐米联合沙利度胺和地塞米松与沙利度胺和地塞米松作为新诊断多发性骨髓瘤患者双自体干细胞移植前诱导治疗和巩固治疗的比较：一项随机 3 期研究。
Lancet. 2010 Dec 18;376(9758):2075-85. doi: 10.1016/S0140-6736(10)61424-9. Epub 2010 Dec 9.
2
Bortezomib plus dexamethasone is superior to vincristine plus doxorubicin plus dexamethasone as induction treatment prior to autologous stem-cell transplantation in newly diagnosed multiple myeloma: results of the IFM 2005-01 phase III trial.硼替佐米联合地塞米松优于长春新碱联合多柔比星联合地塞米松作为新诊断多发性骨髓瘤患者自体造血干细胞移植前的诱导治疗：IFM 2005-01 期 III 期试验结果。
J Clin Oncol. 2010 Oct 20;28(30):4621-9. doi: 10.1200/JCO.2009.27.9158. Epub 2010 Sep 7.
3
Balancing risk versus benefit in the treatment of Waldenström's Macroglobulinemia patients with nucleoside analogue-based therapy.在使用基于核苷类似物的疗法治疗华氏巨球蛋白血症患者时平衡风险与获益
Clin Lymphoma Myeloma. 2009 Mar;9(1):71-3. doi: 10.3816/CLM.2009.n.018.
4
[Clinical experiences with sarcolysin in neoplastic diseases].
Ann N Y Acad Sci. 1958 Apr 24;68(3):1128-32. doi: 10.1111/j.1749-6632.1958.tb42675.x.
5
Multiple myeloma and acute myelomonocytic leukemia.多发性骨髓瘤和急性粒单核细胞白血病。
N Engl J Med. 1970 Nov 19;283(21):1121-5. doi: 10.1056/NEJM197011192832101.
Zotero 插件